NMPA Approval

Trastuzumab Emtansine for Injection

Approval Number

国药准字SJ20200003

Registration Date

November 7, 2024

Previous Approval Numbers

S20200003

Drug Information

Generic Name

注射用恩美曲妥珠单抗

Trade Name

赫赛莱

Dosage Form

注射剂

Strength

100mg/瓶

Drug Type

生物制品

Registration Date

November 7, 2024

Expiry Date

November 6, 2029

Company Address

Grenzacherstrasse 124, 4058 Basel, Switzerland

Company Address

Wurmisweg CH-4303 Kaiseraugst Switzerland

Empowering clinical research with data-driven insights and AI-powered tools.

注射用恩美曲妥珠单抗 - NMPA 批准文号 | MedPath